New video from Motley

[savzak]

www.fool.com/investing/general/2013/12/10/will-mannkind-inhale-novo-nordisks-profits.aspx

They are not all that positive on Afrezza but the only point they argue or even mention is market penetration. No comment at all on funding, approval, labeling or partnership.

[biotec]

At least it wasn't an all out slam of Afrezza.

[savzak]

Dec 11, 2013 10:20:39 GMT -5 biotec said:

At least it wasn't an all out slam of Afrezza.

Right.  I actually thought the video was positive overall, despite the fact that these two fellows are obviously cautious at best about Afrezza's prospects.  When Afrezza's skeptics emphasize market penetration to the exclusion of approval and partnership the clear implication is that they are acknowledging those are not areas for concern.  I think all longs will be much more relaxed when the only remaining question is market penetration.